Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2005;330:1331-1332 (4 June), doi:10.1136/bmj.330.7503.1331-c
| The first 150 words of the full text of this article appear below. |
EDITORHeath describes a current trend that has to be kept in check.1 Recent research findings may strike everyone with mortal fear on occasion. Multinational companies do their bit to allay this fear by producing "antidotes" at an equally rapid pace and at "competitive prices," lest others overtake them in their philanthropy.
Maybe if someone lands on Mars some day there will be a big hoarding showing possible health hazards, and another, equally big if not bigger hoarding, announcing what products are available as antidotes and investigative facilities, with possibly a tag mentioning that a percentage of every purchase is for the poor people of Planet Earth.
In close knit societies that take care of their weak, infirm, and old people, as in the remote villages of India and Botswana, people are not that worried as they age because they know that they will be looked after to the
Rajesh Chauhan, consultant in family medicine and communicable diseases
309/9 AV Colony, Sikandra, Agra-282007, India drchauhanrajesh@yahoo.com
Akhilesh Kumar Singh, senior resident neurology, Parul Kushwah, family medicine practitioner
309/9 AV Colony, Sikandra, Agra-282007, India